57 related articles for article (PubMed ID: 10925698)
1. Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial.
Graham MA; Senan S; Robin H; Eckhardt N; Lendrem D; Hincks J; Greenslade D; Rampling R; Kaye SB; von Roemeling R; Workman P
Cancer Chemother Pharmacol; 1997; 40(1):1-10. PubMed ID: 9137522
[TBL] [Abstract][Full Text] [Related]
2. A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumors.
Dees EC; Whitfield LR; Grove WR; Rummel S; Grochow LB; Donehower RC
Clin Cancer Res; 2000 Oct; 6(10):3885-94. PubMed ID: 11051234
[TBL] [Abstract][Full Text] [Related]
3. Application of pharmacokinetically guided dose escalation with respect to cell cycle phase specificity.
Fuse E; Kobayashi S; Inaba M; Suzuki H; Sugiyama Y
J Natl Cancer Inst; 1994 Jul; 86(13):989-96. PubMed ID: 8024657
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetically guided dose-escalation (PGDE) strategy].
Saeki T
Gan To Kagaku Ryoho; 2000 Jul; 27(7):1069-74. PubMed ID: 10925698
[TBL] [Abstract][Full Text] [Related]
5. New approaches in preclinical and clinical pharmacokinetics.
Graham MA; Kaye SB
Cancer Surv; 1993; 17():27-49. PubMed ID: 8137345
[TBL] [Abstract][Full Text] [Related]
6. The impact of pharmacokinetically guided dose escalation strategies in phase I clinical trials: critical evaluation and recommendations for future studies.
Graham MA; Workman P
Ann Oncol; 1992 May; 3(5):339-47. PubMed ID: 1616887
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacology in development of new anticancer agents].
Sasaki Y
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():310-4. PubMed ID: 7986109
[TBL] [Abstract][Full Text] [Related]
8. [Chronochemotherapy for cancer].
Akazawa S
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1191-202. PubMed ID: 9279336
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
